|
2021-06-09 |
2021-06-07 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
3,646
-100.0%
8.27
USD 30,152
|
3,646
-100.0%
|
8.27
|
USD 30,152
|
|
|
2021-05-13 |
2021-05-12 |
S
Sale
|
Skvarka Jan
President and CEO
Executive Director
|
23,802
-100.0%
9.24
USD 219,880
|
23,802
-100.0%
|
9.24
|
USD 219,880
|
|
|
2021-05-13 |
2021-05-11 |
S
Sale
|
Skvarka Jan
President and CEO
Executive Director
|
106,698
-100.0%
9.20
USD 981,803
|
106,698
-100.0%
|
9.20
|
USD 981,803
|
|
|
2021-04-09 |
2021-04-07 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
3,646
-100.0%
10.82
USD 39,450
|
3,646
-100.0%
|
10.82
|
USD 39,450
|
|
|
2021-03-15 |
2021-03-12 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
2,917
-100.0%
11.97
USD 34,916
|
2,917
-100.0%
|
11.97
|
USD 34,916
|
|
|
2021-03-12 |
2021-03-10 |
PS
Planned sale
|
Petrova Penka
Chief Development Officer
Officer
|
5,312
-100.0%
11.08
USD 58,857
|
5,312
-100.0%
|
11.08
|
USD 58,857
|
|
|
2021-03-10 |
2021-03-08 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
3,646
-100.0%
10.11
USD 36,861
|
3,646
-100.0%
|
10.11
|
USD 36,861
|
|
|
2021-02-10 |
2021-02-09 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
584
-100.0%
14.12
USD 8,248
|
584
-100.0%
|
14.12
|
USD 8,248
|
|
|
2021-02-10 |
2021-02-09 |
PS
Planned sale
|
Petrova Penka
Chief Development Officer
Officer
|
508
-100.0%
14.17
USD 7,200
|
508
-100.0%
|
14.17
|
USD 7,200
|
|
|
2021-02-10 |
2021-02-08 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
6,563
-100.0%
12.65
USD 83,022
|
6,563
-100.0%
|
12.65
|
USD 83,022
|
|
|
2021-02-10 |
2021-02-08 |
PS
Planned sale
|
Petrova Penka
Chief Development Officer
Officer
|
5,312
-100.0%
12.65
USD 67,197
|
5,312
-100.0%
|
12.65
|
USD 67,197
|
|
|
2021-01-15 |
2021-01-14 |
PS
Planned sale
|
Skvarka Jan
President and CEO
Executive Director
|
19,581
-100.0%
15.03
USD 294,279
|
19,581
-100.0%
|
15.03
|
USD 294,279
|
|
|
2021-01-15 |
2021-01-13 |
PS
Planned sale
|
Skvarka Jan
President and CEO
Executive Director
|
5,419
-100.0%
15.04
USD 81,508
|
5,419
-100.0%
|
15.04
|
USD 81,508
|
|
|
2021-01-13 |
2021-01-11 |
PS
Planned sale
|
Petrova Penka
Chief Development Officer
Officer
|
508
-100.0%
15.21
USD 7,725
|
508
-100.0%
|
15.21
|
USD 7,725
|
|
|
2021-01-13 |
2021-01-11 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
584
-100.0%
15.20
USD 8,879
|
584
-100.0%
|
15.20
|
USD 8,879
|
|
|
2021-01-12 |
2021-01-08 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
2,917
-100.0%
15.51
USD 45,230
|
2,917
-100.0%
|
15.51
|
USD 45,230
|
|
|
2021-01-12 |
2021-01-08 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
5,600
-100.0%
15.82
USD 88,575
|
5,600
-100.0%
|
15.82
|
USD 88,575
|
|
|
2021-01-12 |
2021-01-08 |
PS
Planned sale
|
Parsons James T.
Chief Financial Officer
Officer
|
8,505
-100.0%
15.79
USD 134,271
|
8,505
-100.0%
|
15.79
|
USD 134,271
|
|
|
2021-01-12 |
2021-01-08 |
PS
Planned sale
|
Petrova Penka
Chief Development Officer
Officer
|
2,604
-100.0%
15.50
USD 40,365
|
2,604
-100.0%
|
15.50
|
USD 40,365
|
|
|
2021-01-11 |
2021-01-07 |
PS
Planned sale
|
Petrova Penka
Chief Development Officer
Officer
|
2,708
-100.0%
14.71
USD 39,843
|
2,708
-100.0%
|
14.71
|
USD 39,843
|
|
|
2021-01-11 |
2021-01-07 |
PS
Planned sale
|
Uger Robert
Chief Scientific Officer
Officer
|
3,646
-100.0%
14.75
USD 53,782
|
3,646
-100.0%
|
14.75
|
USD 53,782
|
|
